Company profile

WellDoc

Chronic Disease Management & Digital Therapeutics

Company profile

About WellDoc

WellDoc is a digital health company that transforms fragmented cardiometabolic data into actionable insights through clinically-validated AI technology. The company's platform serves as a bridge connecting members, care teams, and healthcare partners with personalized, predictive solutions built for real-world healthcare delivery. WellDoc's core technology analyzes over 680 unique metrics across 80 health domains annually per user, powered by half a billion data points, to deliver truly personalized health management. The company offers multiple solutions including FDA-cleared medical devices for type 1 and type 2 diabetes management, comprehensive weight management programs (including GLP-1 medication support), and broader cardiometabolic health solutions. WellDoc's platform integrates seamlessly with existing healthcare infrastructure through flexible partnership models, supporting branded and white-label implementations, companion apps for pharmaceutical and medical device companies, and direct integrations via SDK or API. With 11 FDA 510(k) clearances, 67 patents, and over 100 clinical publications, WellDoc has established itself as a leader in regulatory-grade digital health technology. The platform currently supports 53 million covered lives and connects to 400+ devices and data sources. WellDoc serves multiple customer segments including life sciences and medtech companies, health plans and PBMs, employers, healthtech companies, DMEs, and health systems. The company partners with major healthcare organizations including CVS Health and Eli Lilly to deliver proven outcomes in chronic disease management.

Company description WellDoc official website

Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at WellDoc?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Brain health
  • Cardiometabolic conditions
  • Complex chronic conditions
  • Hypertension
  • Immunology
  • Oncology
  • Type 1 diabetes
  • Type 2 diabetes
  • Weight management

Who it serves

  • DMEs
  • Employers & Consultants
  • Health Plans & PBMs
  • Health Systems & Providers
  • HealthTech companies
  • Life Sciences & MedTech

Deployment & integration

Api Only · Cloud Saas deployment with recorded integration context.

Recorded integration context: 400+ connected devices including CGMs, scales, blood pressure cuffs, DTC services, EHR systems, Existing healthcare portals and proprietary applications, Pharmacy connectivity.

Geographic context

MarketsCanada · European Union · Japan · United States
Company sourceOfficial website

Company milestones

Platform expansion

Named 'Best Overall Digital Health Company' for 4th consecutive year in MedTech Breakthrough Awards (2025). Launched personalized companion app for leading life sciences company supporting incretin-based therapies. Currently supports 53 million covered lives.

Partnerships

Recorded partners

  • CVS Health
  • CVS Healthspire
  • Eli Lilly
  • Leading life sciences company (unnamed - incretin-based therapy companion app)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

BlueStar

FDA-cleared digital therapeutic for type 1 and type 2 diabetes management

Software · Cloud SaaSCompany source

Branded & White Label Solutions

Customizable companion apps for life sciences and medtech companies

Platform · Api OnlyCompany source

CVS Healthspire Weight Management Program

Turn-key weight management program combining Welldoc AI with virtual clinical support

Service · Cloud SaaSCompany source

Welldoc Diabetes Rx

FDA-cleared prescription digital therapeutic for diabetes management

Software · Cloud SaaSCompany source

Welldoc Platform

Healthcare-ready AI platform transforming cardiometabolic data into actionable insights

Platform · Cloud SaaSCompany source

Welldoc Weight Management

Complete weight management solution integrating GLP-1s, behavior change, and AI

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

47% reduction in anti-obesity medication spend

CVS Healthspire weight management program

18.5% average weight loss

Program members taking anti-obesity medication for one year

2:1 observed ROI

Enhanced weight management program

92% member satisfaction

Weight management program participants

CVS Health

Weight management program for members using anti-obesity medications

Up to 47% less client spend on anti-obesity medication, 18.5% average weight loss for program members taking AOM, 2:1 observed ROI, 92% member satisfaction

Leading Life Sciences Company

Personalized companion app for individuals using incretin-based therapies for cardiometabolic support

Comprehensive cardiometabolic support with medication reminders, dose logging and device connectivity

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from WellDoc

Recent articles published on WellDoc's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Chronic Disease Management & Digital Therapeutics

Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon